Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity

Molecular and Cellular Biology

Volumn 25, Issue 8, 2005, Pages 2885-2898

  Narayanan, Ramesh ^a   Edwards, Dean P ^b   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; PROGESTERONE RECEPTOR; SERINE; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TRICHOSTATIN A;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE MAMMARY TUMOR ONCOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; TURNOVER TIME;

ACETYLTRANSFERASES; ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASES; CYTOPLASM; ENZYME INHIBITORS; GENES, REPORTER; HISTONE ACETYLTRANSFERASES; HUMANS; HYDROXAMIC ACIDS; MAMMARY TUMOR VIRUS, MOUSE; MICE; PHOSPHORYLATION; PROMEGESTONE; PROMOTER REGIONS (GENETICS); RECEPTORS, PROGESTERONE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; TUMOR VIRUS;

EID: 16244382046     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.8.2885-2898.2005     Document Type: Article

References (45)

1. 2 and mitosis. Mol. Endocrinol. 16:1352-1366.
2. Ait-Si-Ali, S., S. Ramirez, F.-X. Barre, F. Dkhissi, L. Magnaghi-Jaulin, J. A. Girault, P. Robin, M. Knibiehler, L. L. Pritchard, B. Ducommun, D. Trouche, and A. Harel-Bellan. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184-186.
3. Apostolakis, E. M., R. Lanz, and B. W. O'Malley. 30 October 2003, posting date. Pituitary adenylate cyclase activating peptide (PACAP): a pivotal modulator of steroid-induced reproductive behavior in female rodents. Mol. Endocrinol. 18:173-183. [Online.]
4. Bodwell, J. E., J. C. Webster, C. M. Jewell, J. A. Cidlowski, J. M. Hu, and A. Munck. 1998. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65:91-99.
5. Boonyaratanakornkit, V., M. P. Scott, V. Ribon, L. Sherman, S. M. Anderson, J. L. Mailer, W. T. Miller, and D. P. Edwards. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8:269-280.
6. Carson-Jurica, M. A., W. T. Schrader, and B. W. O'Malley. 1990. Steroid receptor family: structure and functions. Endocr. Rev. 11:201-220.
7. Cato, A. C. B., D. Henderson, and H. Ponta. 1987. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J. 6:363-368.
8. Chou, C. F., and M. B. Omary. 1994. Mitotic arrest with anti-microtubule agents or akadaic acid is associated with increased glycoprotein terminal GIcNAc's. J. Cell Sci. 107:1833-1843.
9. Clemm, D. L., L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards. 2000. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site specific monoclonal antibody. Mol. Endocrinol. 14:52-65.
10. Conneely, O. M., B. Mulac-Jericevic, J. P. Lydon, and F. J. DeMayo. 2001. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol. Cell. Endocrinol. 179:97-103.
11. Cram, E. J., B. D. Liu, L. F. Bjeldanes, and G. L. Firestone. 2001. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J. Biol. Chem. 276:22332-22340.
12. Gioeli, D., S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, and M. J. Weber. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277:29304-29314.
13. Hissom, J. R., and M. R. Moore. 1987. Progestin effects on growth in the human breast cancer cell line T-47D - possible therapeutic implications. Biochem. Biophys. Res. Commun. 145:706-711.
14. Horwitz, K. B., M. B. Mockus, and B. A. Lessey. 1982. Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance. Cell 28:633-642.
15. Hu, J. M., J. E. Bodwell, and A. Munck. 1994. Cell cycle-dependent glucocorticoid receptor phosphorylation and activity. Mol. Endocrinol. 8:1709-1713.
16. Karin, M., A. Haslinger, H. Holtgreve, R. I. Richards, P. Krauter, H. M. Westphal, and M. Beato. 1984. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308:513-519.
17. Kastner, P., A. Krust, B. Turcotte, U. Strupp, L. Tora, H. Gronemeyer, and P. Chambon. 1990. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603-1614.
18. Knotts, T. A., R. S. Orkiszewski, R. G. Cook, D. P. Edwards, and N. L. Weigel. 2001. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J. Biol. Chem. 276:8475-8483.
19. Knudsen, K. E., W. K. Cavenee, and K. C. Arden. 1999. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res. 59:2297-2301.
20. Lambert, J. R., and S. K. Nordeen. 2001. Analysis of steroid hormone-induced histone acetylation by chromatin immunoprecipitation assay. Methods Mol. Biol. 176:273-281.
21. Lange, C. A. 16 October 2003, posting date. Making sense of cross-talk between steroid hormone receptor and intracellular signaling pathways: who will have the last word? Mol. Endocrinol. 18:269-278. [Online.].
22. Lange, C. A., T. Shen, and K. B. Horwitz. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. USA 97:1032-1037.
23. LeGoff, P., M. M. Montano, D. J. Schodin, and B. S. Katzenellenbogen. 1994. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:4458-4466.
24. Li, X., J. Wong, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 2003. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 23:3763-3773.
25. Lim, C. S., C. T. Baumann, H. Htun, W. Xian, M. Irie, C. L. Smith, and G. L. Hager. 1999. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol. Endocrinol. 13:366-375.
26. Martinez, E. D., and M. Danielsen. 2002. Loss of androgen receptor transcriptional activity at the G(1)/S transition. J. Biol. Chem. 277:29719-29729.
27. Maurer-Schultze, B., M. Siebert, and I. D. Bassukas. 1988. An in vivo study on the synchronizing effect of hydroxyurea. Exp. Cell Res. 174:230-243.
28. Mulac-Jericevic, B., J. P. Lydon, F. J. DeMayo, and O. M. Conneely. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. USA 100:9744-9749.
29. Musgrove, E. A., C. S. L. Lee, and R. L. Sutherland. 1991. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes. Mol. Cell. Biol. 11:5032-5043.
30. Narayanan, R., A. A. Adigun, D. P. Edwards, and N. L. Weigel. 2004. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol. Cell. Biol. 25:264-277.
31. Narayanan, R., V. A. Tovar Sepulveda, M. Falzon, and N. L. Weigel. 2004. The functional consequences of cross talk between the vitamin D receptor and ERK signaling pathways are cell specific. J. Biol. Chem. 279:47298-47310.
32. Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17:5338-5347.
33. Olea-Serrano, N., N. Deuleeschouwer, G. Leclercq, and J. C. Henson. 1985. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur. J. Cancer Clin. Oncol. 21:965-973.
34. Qiu, M., A. Olsen, E. Faivre, K. B. Horwitz, and C. A. Lange. 2003. Mitogen activated protein kinase regulates nuclear association of human progesterone receptors. Mol. Endocrinol. 17:628-642.
35. Richer, J. K., B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz. 2002. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209-5218.
36. Shen, T., K. B. Horwitz, and C. A. Lange. 2001. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent downregulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 21:6122-6131.
37. Slater, E. P., A. C. B. Cato, M. Karin, J. D. Baxter, and M. Beato. 1988. Progesterone induction of metallothionein-IIA gene expression. Mol. Endocrinol. 2:485-491.
38. Stenoien, D. L., M. G. Mancini, K. Patel, E. A. Allegretto, C. L. Smith, and M. A. Mancini. 2000. Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1. Mol. Endocrinol. 14:518-534.
39. Stenoien, D. L., K. Patel, M. G. Mancini, M. Dutertre, C. L. Smith, B. W. O'Malley, and M. Mancini. 2001. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent. Nat. Cell Biol. 3:15-23.
40. Tsai, M.-J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451-486.
41. Weigel, N. L., C. A. Beck, P. A. Estes, P. Prendergast, M. Altmann, K. Christensen, and D. P. Edwards. 1992. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol. Endocrinol. 6:1585-1597.
42. Xu, Y., L. Klein-Hitpass, and M. K. Bagchi. 2000. E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex. Mol. Cell. Biol. 20:2138-2146.
43. Yamamoto, A., Y. Hashimoto, K. Kohri, E. Ogata, S. Kato, K. Ikeda, and M. Nakanishi. 2000. Cyclin E as a coactivator of the androgen receptor. J. Cell Biol. 150:873-880.
44. Zhang, Y., W. Bai, V. E. Allgood, and N. L. Weigel. 1994. Multiple signaling pathways activate the chicken progesterone receptor. Mol. Endocrinol. 8:577-584.
45. Zhang, Y., C. A. Beck, A. Poletti, D. P. Edwards, and N. L. Weigel. 1995. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol. Endocrinol. 9:1029-1040.